FDA Investigator Paul Z Balcer
Paul Z Balcer has conducted inspections on 54 sites in 3 countries as of 01 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
54
Last Inspection Date:
01 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Puerto Rico,
Mexico
FDA Investigators that have inspected at least one site in common with Paul Z Balcer:
Adaliz Santaliz Cruz,
Alan A Rivera,
Alan P Kurtzberg,
Alicia A Armijo,
Andrea George, PhD,
Andrea J Schmidt,
Andrew J Gonzales,
Andrew M Kolenc,
Ann Marie Montemurro,
Antonetta M Colacchio,
Arlene M Badillo,
Ashleigh P Barkans,
Ashleigh P Wodushek,
Ashley M Caputo,
Ashley N Queen, PhD,
Azotearc,
Bodenw,
Brent W Higgs,
Brittany R Laymon,
Bryce A Hammer,
Calvin B Koerner,
Carla Lankford, MD, PhD,
Carla R Hinz,
Carmen Ramirez,
Caroline H Le,
Carrie E Jolly,
Christine I Shaw,
Christine L Williams,
Christopher Downey, PhD,
Colleen Thomas, PhD,
Connie Lucero,
Daniel J Lahar,
Daniel Pst Laurent,
David A Gonzalez,
David Frucht, MD,
Debra L Curtis,
Dennis Cantellops Paite,
Donald C Obenhuber, PhD,
Dov H Pluznik, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Duc Minh H Nguyen,
Edith M Gonzalez,
Eliezar Ramos,
Elisa J Beard,
Elvin R Smith,
Eric C Behrens,
Eric S Myskowski,
Erika V Butler,
Felix J Marrero,
Frank L Cordova,
Gary C Pecic, Jr,
Gina M Scholze,
Ginger M Sykes,
Grace E Mcnally,
Hanna L Potter,
Harry A Wilson,
Holly L Miller,
Isabel Y Espinosa,
Isaiah D Isakson,
Ivis L Negron,
Jacqueline Mdiaz Albertini,
James R Montero,
Jamie L Dion,
Jamie L Port,
Janet Pulver,
Jennifer A Baker,
Jennifer Lalama,
Jennifer R Mathern,
Jerri Baker,
Jianming Li,
Jin M Kim,
Joel D Hustedt,
John A Gonzalez,
Jorge L Lajara,
Jose A Lopez,
Jose Acruz Gonzalez,
José E Meléndez,
Jose R Lopez,
Jose Velez,
Joshua C Schafer,
Judy M Amaya,
Kalavati Suvarna, PhD,
Kathryn M Mogen,
Keith C Littrell,
Kimberley A Hoefen,
Kristen E Szenderski,
Larry Gehring,
Laura B Kennedy,
Lavender M Huskey,
Libia M Lugo,
Linda M Cheny,
Lisa Shin,
Lisa T Michel,
Lori A Carr,
LT Rafael Gonzalez,
Manuel A Moreno,
Maria Gutierrez Lugo, PhD,
Marian E Ramirez,
Marie B Buen Bigornia,
Marlene G Swider,
Marlo Ianm Alintanahin,
Marquez D Berrianvalle,
Marsha L Mccauley,
Mary F Bodick,
Matthew A Johnson,
Matthew M Vernon,
Matthew R Dionne,
Maxwell Van Tassell, PhD,
Meaghan M Rabideau,
Michael A Charles,
Michael E Maselli,
Michael J Kuchta,
Michael L Zimmerman,
Michael R Goga,
Michael Shanks, MS,
Michelle D Motsinger,
Michelle Yclark Stuart,
Mihaly S Ligmond,
Milva E Melendez Perales,
Myriam M Sosa,
Nancy G Schmidt,
Nathan R Moon,
Nayan J Patel,
Nicholas Obiri, PhD,
Nikolay Spiridonov,
Noreen Muñiz,
Nydia E Colon,
Oluwaseyi Ojinni,
Omotunde O Osunsanmi,
Patricia A Brown,
Patricia A Cortez,
Patricia A Maestas,
Patricia F Hughes, PhD,
Patrick W Mcafee,
Paul J Teitell,
Paul Lihong Yeh, PhD,
Paula A Trost,
Ramesh Potla, PhD,
Ramon A Hernandez,
Rebecca E Dombrowski,
Rebecca Parrilla,
Rebecca Rodriguez,
Rebecca S Secrist,
Richard W Thornton,
Ricki A Chase,
Riley C Myers, PhD,
Robert D Tollefsen,
Robert Darius,
Rose Ashley,
Samantha E Rafferty,
Shererk,
Solomon G Williams,
Sri H Pfuntner,
Steve P Yost,
Steven C Madzo,
Steven Fong, MS, PhD,
Steven O Gauthier,
Susan F Laska, MS,
Teena H Aiken,
Thai T Duong,
Theressa B Smith,
Thomas J Arista,
Thomas V Anderson,
Timothy Wadkin, PhD,
Traci B Bickell,
Trevor R Beach,
Verlinda A Narcisse,
Vilmary Negron Rodriguez,
Wendy G Tan, PhD,
William A Warnick,
William D Boden,
William J Leonard,
Zachary L Miller,
Zachary L Stamm,
Zhong Li, PhD
Paul Z Balcer's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2015 | FDA 483 Response | Amgen, Inc. - Form 483R, 2015-02-27 |
February, 2015 | FDA 483 | Amgen, Incorporated - Form 483, 2015-02-11 |
February, 2013 | FDA 483 | Kasel Associates Industries, Inc. - Form 483, 2013-02-14 |
February, 2014 | FDA 483 | Smiley National Inc - Form 483, 2014-02-28 |
February, 2015 | EIR | Amgen, Inc. - EIR, 2015-02-11 |
April, 2015 | FDA 483 | Dysal S.A. de C.V. - Form 483, 2015-04-28 |
February, 2015 | FDA 483 | Amgen, Inc. - Form 483, 2015-02-11 |
January, 2015 | FDA 483 | Zynex Medical, Inc. - Form 483, 2015-01-29 |
February, 2013 | EIR | Kasel Associates Industries, Inc. - EIR, 2013-02-14 |
February, 2015 | EIR | Amgen, Incorporated - EIR, 2015-02-11 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more